We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Psoriasis and Cardiometabolic Comorbidities: An Evaluation of the Impact of Systemic Treatments in Randomized Clinical Trials.
- Authors
Mosca, Megan; Hong, Julie; Hadeler, Edward; Hakimi, Marwa; Brownstone, Nicholas; Liao, Wilson; Bhutani, Tina
- Abstract
The association between psoriasis, metabolic syndrome, and cardiovascular disease is well established. The shared pathways between psoriasis, metabolic syndrome, and atherosclerosis suggest that treatments targeting the inflammatory pathways of psoriasis may also be beneficial in the treatment of associated cardiometabolic comorbidities. This paper reviews the most recent data regarding the impact of systemic psoriasis treatments on comorbid cardiovascular and metabolic disease. Data from randomized clinical trials with systemic and biologic agents are presented. Overall, studies demonstrate beneficial effects on several cardiometabolic markers and risk factors in psoriasis patients; however, longer randomized controlled trials to characterize the direct benefit for cardiovascular outcomes are needed.
- Subjects
CLINICAL trials; CARDIOVASCULAR diseases; ATHEROSCLEROSIS; PSORIASIS; PSORIATIC arthritis; BIOLOGICALS; METABOLIC syndrome
- Publication
Dermatology & Therapy, 2021, Vol 11, Issue 5, p1497
- ISSN
2193-8210
- Publication type
Article
- DOI
10.1007/s13555-021-00590-0